Professional Documents
Culture Documents
REVIEW
Eye Pathology Laboratory, Wilmer Ophthalmological Institute and Department of Pathology, The Johns
Ilopkins Hospital, Baltimore, Maryland
Abstract . Leukemia may involve almost any ocular tissue, by direct infiltration, by hemorrhage,
and by ischemic changes . Both acute and chronic leukemia can cause ocular signs, either initially
or later in the disease process ; the clinical features and pathologic correlations of this involvement
are reviewed . Also, various chemotherapeutic agents used to treat leukemia may cause ocular
toxicity . Recently, bone marrow transplants have been performed more frequently in an attempt
to prolong patient survival ; if graft-versus-host disease results, one symptom is' dry eyes from
alacrima . Superimposed infection due to immunosuppression can occur from the disease itself or
from treatment . Recognition by the ophthalmologist of the various ocular signs is important in
assessing the course and prognosis of leukemia . (Surv Ophthalmol 27 :211-232, 1983)
t is a truism that the eye often reflects the disease I. Systemic Leukemia and Classification
I states of the body, and this is certainly so for the
leukemias .
Before the advent of bone marrow biopsy, oph-
The leukemias may be divided into acute and
chronic types, based on differences in presentation
thalmologists were routinely consulted to assist in and clinical course . The acute leukemias present
the diagnosis of leukemia ." They looked for leuke- with the signs and symptoms of anemia, hemor-
mic retinopathy, which was often present, although rhage, and infection, and also with infiltration of the
frequently asymptomatic . The bone marrow biopsy lymph nodes, spleen, and liver . If acute leukemia is
has tended to replace the ophthalmologist in con- untreated, death ensues usually a few months after
firming the diagnosis, but he or she is still likely to diagnosis . Chemotherapy, however, has allowed
encounter patients with leukemia at all stages of the prolonged remission, especially in acute lymphocyt-
disease . Indeed, eye symptoms may be the initial ic leukemia which has a 50% core rate in childhood .
presentation of leukemia . The leukemias are also classified by cell type .
Therefore, a review of ocular involvement in leu- Acute lymphocytic leukemia (ALL) probably arises
kemia is appropriate, especially as survival time for from lymphoid tissue, although its first clinical
patients with acute leukemia has increased dramati- manifestations occur after abnormal population of
cally with chemotherapy and bone marrow trans- the bone marrow . Acute myelocytic leukemia
plantation . Current estimates of leukemic involve- (AML) arises from the marrow hematopoietic stem
ment of the eye at some point in the course of the cell, or from one of the more differentiated marrow
disease range as high as 90% of cases ." cells, and it is named for that cell . Thus, one can
211
tes may have played a role in the development of controlled, and neovascularization would therefore
peripheral new vessels . seem to be less likely than in earlier years .
None of the postmortem eyes in our series had The more common manifestations of leukemic
neovascularization . Now that better control of the retinopathy, such as venous dilatation, hemor-
white count can be achieved with leukemia therapy, rhages, and cotton-wool spots, are not unique to
blood viscosity and resultant ischemia can be better leukemia ; similar findings are seen in severe ane-
Fig. 6. E .P . 30259 . This 33-year-old white woman died after a 7-month history of acute myelogenous leukemia with an
intracranial hemorrhage . Leukemic infiltration of the dura was found at autopsy . Left : There is elevation and disruption
of overlying retina by a massive infiltrate ofleukemic cells . Right : A large infiltrate ofleukemic cells, and hemorrhage, has
detached and partly destroyed overlying retina . Some areas of necrosis (asterisk) are present (hematoxylin and eosin ; A,
x 130 : B, x 30) .
Fig . 7. E .P. 43347 . A 43-year-old white woman was diagnosed as having chronic myelogenous leukemia by ,bone-marrow
aspiration . I8 months later, she developed a blast crisis unresponsive to therapy and died less than a month later . The
brain was normal by postmortem examination, but both eyes were found to have capillary mic oaneurysnis throughout
the retina . Left : Low-power view of a trypsin-digestion preparation of retinal vessels, showing saccular (arrowhead) and
fusiform (arrow) microaneurysms . Some of the capillaries arc acellular (asterisks) (periodic acid-Schiff, x 75) . Right :
High-power view of a fusiform aneurysm (asterisk) . There is a decreased number of endothelial cells (arrows) and a lesser
decrease of pericytes (arrowheads) (periodic acid-Schlff; A, x 75 : B, x 320) .
11), and cystoid retinal edema (Fig . 12) . also occur with CLIP 7 or leukemia of myeloid ori-
When choroidal involvement is evident clinically, gin ." Leukemia can also be a cause of spontaneous
it usually presents as a serous retinal detachment, hyphema in children . 44 .79,10f,
generally shallow and at the posterior pole . These Increased intraocular pressure may be present,
detachments have been reported in CLL, 75 and can be high enough to cause the signs and
ALL, 12 .102 CML, 4' and AML . 39 They are sometimes symptoms of acute glaucoma, but with an anterior
the first observed manifestation of the leukemic chamber of normal depth .", Increased intraocular
process ."' 7 Fluorescein angiography of the exuda- pressure is sometimes the presenting symptom of
tive detachments demonstrates myriad diffuse leak- leukemia, even without overt iris changes or other
age points at the level of the RPE 57 (Fig . 13) . This ocular manifestations ."
fluorescein pattern, with leakage from pinpoint Ridgway et al" reported nine patients with
RPE defects, also can be seen in ocular malignant anterior segment involvement ; all had or developed
melanoma, Vogt-Koyanagi-Harada syndrome, evidence ofCNS leukemia . Ocular signs and symp-
metastatic tumor, and posterior scleritis 5 7 Eventu- toms included change in iris color, secondary glau-
motherapy, and should be locally irradiated when chronic leukemia, with 14% of eyes (14 of 97 cases)
involved . showing involvement, versus 7 .3% in acute leuke-
mia (17 of 233 cases) . We found 8% (16 of 201)
E. ORBIT
orbital involvement in myeloid leukemia and 12%
All types of leukemia may involve the orbit ; how- (15 of 125) in lymphoid leukemia . Most of these
ever, orbital involvement is more common in acute cases, however, showed a mild diffuse infiltrate,
leukemia than in chronic, and it occurs more often rather than massive tumor formation .
in the lymphoid type than in the myeloid type .`" In Orbital infiltration in leukemia presents with ex-
our series, orbital infiltration was more common in ophthalmos, lid edema and chemosis, with
Fig . 22 . E .P. 10050 . This is from the same patient as Fig . 21 . E .P . 41178 . This is from the same patient as
shown in Fig . 19 and shows a diffuse cellular infiltrate shown in Fig . 14. The lacrimal gland shows a diffuse
around ducts (asterisks) of the lacrimal gland (periodic infiltrate of leukemic cells between acini (arrows) and
acid-Schiff, x 525) . around ducts (hematoxylin and eosin, x 65) .
by leukemic cells . To our knowledge, this has not F. CORNEA AND SCLERA
been evident clinically as an isolated muscle palsy, Because the cornea is normally avascular, direct
but extraocular muscle involvement was present in invasion by leukemic cells would not be expected . In
five cases in our autopsy series, including one case Allen and Straatsma's series,' there was no corneal
with massive infiltration (Fig . 23) . Leukemic infil- involvement beyond limhal infiltration ..
tration may extend into the sinuses, simulating However, leukemia can induce formation of a
sinusitis n sterile ring ulcer with iritis and pannus . 9 In one
Fig . 31 . E .P . 43502 . An 18-year-old girl had ALL and died of gram-negative sepsis . Left : A low-power view of the retina
shows an area of retinal necrosis (asterisk) . The underlying choroid is normal . Right: At higher power, gram-negative
rods are visible within inner retina (Brown and Hopps ; A, x 210 ; B, x 2000) .
However, the eye is part of the central nervous sys- later contained leukemic infiltrates throughout, es-
tem, and as such, is a pharmacologic "sanctuary," pecially posteriorly .
which may not be treated adequately by drugs given Subconjunctival steroid injection" and intrathe-
systemically . 85 cal methotrexate45 have also been reported to be
Prophylaxis for CNS leukemia consisting of in- helpful for iris infiltration and secondary glaucoma ;
trathecal methotrexate and radiation to the head however, Mark and coworkers" found no response
and spine is now routinely given for children with to local steroids .
ALL,', " but, as Ellis and Little 34 demonstrated, the Decreased vision from leukemic infiltration of the
eye is beyond the reach of chemotherapeutic agents optic nerve is an ophthalmic emergency .' Ridgway
injected intrathecally . Ridgway and coworkers" ad- et al" advocate 1000 rads over 5 days ; other au-
vocated prophylactic irradiation to the eyes as well thorsssss,74,H7 have used doses from 700 rads5 to 2000
as the brain, but were unable to suggest a dose . rads A7 with success . Rosenthal and associates 87
We have found no reports describing prophylac- pointed out that papilledema and direct optic nerve
tic radiation given to the eyes or orbits, Radiation involvement may look similar and may coexist ; ex-
has been given, in widely varying dosages and amination of the spinal fluid is needed to diagnose
schedules, for leukemic infiltration of the eye, both CNS leukemia . These authors" also noted that in-
anteriorly and posteriorly, and the orbit . Newman vasion of the retrobulbar optic nerve is much more
and coworkers 76 stated that 800 rads is effective as devastating visually than leukemic invasion at the
local therapy in 90% of patients, but did not give disc.
details in their series . Orbital involvement by AML (granulocytic sar-
Local irradiation, along with systemic chemo- coma) 'o and ALL (lymphoblastoma) 73 :8' carries a
therapy for the underlying disease, can help resolve very poor prognosis despite radiation and chemo-
iris infiltration, pseudohypopyon, and accompany- therapy . Quite evidently, it is possible to treat ocu-
ing elevated intraocular pressure . ,?sua8,74,n,bou Mar- lar manifestations of leukemia successfully, but
tinfi 7 used 500 rads during a six-day period, and there is as yet no standardized protocol, nor has the
Masera and coworkers" used 390 rads during a 22- use of prophylactic radiation to the eyes and orbit
day period, to induce clinical resolution . Fonken been adequately addressed to date .
and Ellis 37 used an even lower dose, 250 rads over
K. DRUG TOXICITY
five days, to treat iris infiltration, glaucoma, and
leukemic retinopathy . Clinically, they were success- Many cytotoxic drugs have been developed for
ful, but the eyes obtained postmortem two months the treatment of leukemia and other cancers, and it
OCULAR AND ORBITAL INVOLVEMENT IN LEUKEMIA 229
marrow is completely destroyed by irradiation and LW, Green WR, Tutschka PJ, Santos GW, Be-
chemotherapy, a transplant from the bone marrow schorner WE, personal communication, 1981) . The
of an HLA-compatible sibling is performed . Ideally, choroid contains unusual-appearing histiocytes
these normal cells proliferate, giving the host nor- with granular, densely eosinophilic cytoplasm
mal red cell, white cell, and platelet function . (Fig . 34) .
Two serious complications may arise . Despite ap-
parently adequate pretreatment, the leukemic cell III . Conclusion
line may recur, requiring further chemotherapy ."
The leukemias can cause numerous intraocular
In some cases, leukemic transformation has been
and extraocular changes . Although some of these
proven to occur in the grafted cells ." are rare, they can still be of prognostic significance .
In addition, because the implanted lymphocytes
All of the main manifestations of leukemic involve-
are immunocompetent, and because our present
ment can be explained on the basis of anemia and
ability to detect immunocompatibility is imperfect,
hypoxia, blood hyperviscosity, compression by
the risk of acute and chronic graft-versus-host dis-
masses of cells, or direct tumor infiltration . Various
ease is very real . The transplanted white cells recog-
other effects occur from superinfection or from
nize the host as foreign, and attack host tissue .
therapeutic procedures, such as radiation, chemo-
Acute graft-versus-host disease (GVHD) manifes-
therapy, or bone marrow transplant .
tations include fever, skin rash, dry mouth, enteritis,
and hepatitis . Chronic GVHD presents as a Sjo-
Acknowledgments
gren's or scleroderma-like illness ."
Ocular manifestations of GVHD include dry We thank Dr . Rein Saral for review of the manuscript
eyes, pseudomembranous conjunctivitis, ectropion and Mr . James David Andrews and Ms . Marcia Kelley
of the lid, and uveitis . The patient's sensation of dry for assistance during preparation of the manuscript .
eyes can be verified by the Schirmer test . In severe
cases the cornea may undergo keratinization . References
On histopathologic examination, the cornea and 1 . Abbassioum K : Headaches, vomiting and diplopia in a 16-
conjunctiva in graft-versus-host disease show thin- year-old boy . Clin Pediat 78.191-192, 1979
2 . Albert DW, Wong VG, Henderson ES : Ocular complications
ning (Fig . 32) and, in more severe cases, keratiniza- of vincristine therapy . Arch Ophthalntal 78:709-713, 1967
tion . The lacrimal gland shows flattening of the 3, Allen RA, Straatsma BR : Ocular involvement in leukemia and
acini and inspissation of eosinophilic periodic-acid- allied disorders . Arch Ophthalmol 66 .-490-508, 1961
4 . Al-Rashid RA : Papilledema and ataxia as initial manifestation
Schif -positive material in the tear ducts, and also of acute lymphocytic leukemia . JPed Ophthalmol8:29-30, 1971
within the secretory cells (Fig . 33) (Jabs DA, Hirst 5 . Al-Rashid RA, Cress C : Mumps uveitis complicating the
course of acute leukemia . J Ped Ophthalmol 14 :100-102, 1977 35. Engel HM, Green WR, Michels RG, et al : Diagnostic vitrec-
6 . Anderson B, Anderson B Jr: Necrotizing uveitis incident to tomy . Retina 1 :121-149, 1981
perfusion of intracranial malignancies with nitrogen mustard 36. Ericson L, Karlberg B, Rosengren BHO : Trials of intravitreal
or related compounds. Traps Am Ophthalmol Soc58:95-105, 1960 injections of chemotherapeutic agents in rabbits . Acta Ophthal-
7 . Ballantyne AJ, Michaelson IC : Textbook of the Fundus ofthe Eye . mol 42:721-726, 1964
Baltimore, Williams and Wilkins, 1970, pp 290-292 37 . Fonken HA, Ellis PP : Leukemic infiltrates in the iris . Arch
8. Ballard JO, Towfrghi J, Brennan RW, et al : Neurologic com- Ophthalmol 76 :32-36, 1966
plications of acute myelomonoblastic leukemia of four years' 38 . Frank RN, Ryan SJ Jr: Peripheral retinal neovascularization
duration . Neurology 28:174-178, 1978 with chronic myelogenous leukemia . Arch Ophthalmol 87 : 585-
9. Bhadresa GN : Changes in the anterior segment as a presenting 589, 19972
feature in leukaemia . Br J Ophthalmol 55133-135, 1971 39 . Gass JDM : D fermtial Diagnosis of Intraomlar Tumors : A Stereo-
10. Blodi FC : The difficult diagnosis of choroidal melanoma . Arch scopic Presentation . St Louis, CV Mosby, 1974, pp 160-176
Ophthalmol69.253-256, 1963 40 . Glaser B, Smith JL: Leukaemic glaucoma . Br J Ophthalmol
11 . Brown GC, Shields JA, Augsburger JJ, et al : Leukemic optic 50:92-94, 1966
neuropathy. Int Ophthalmol3 :111-116, 1981 41 . Green WR : Retinal and optic nerve atrophy induced by intra-
12 . Burns CA, Blodi FC, Williamson BK : Acute lymphocytic leu- vitreous vincristine in the primate . Tram Am Ophthalmol Soc
kemia and central serous retinopathy. Tram Am Acad Ophthal- 73:389-416, 1975
mol Otolaryngol69 :307-309, 1965 42 . Greene WH, Wiernik PH : Candida endophthalmitis : Success-
13 . Camras CB, Bito LZ : The pathophysiological effects of nitro- ful treatment in a patient with acute leukemia . Am JOphthalmol
gen mustard on the rabbit eye . I . The biphasic intraocular 74:1100-1102, 1972
pressure response and the role of prostaglandins . Rep Eye Res 43 . Hine JE, Kingham JD : Myelogenous leukemia and bilateral
30 :41-52, 1980 exudative retinal detachment . Ann Ophthalmot 11 :1867-1872,
14 . Cannellos GP, Whang-Peng J, Schnipper L, et al : Prolonged 1979 . (Also Compr Therapy 5:5`-58, 1979)
cytogenetic and hematologic remission of blastic transforma- 44 . Hinzpeter EN, Knobel H, Freund J : Spontaneous haemoph-
tion in chronic granulocytic leukemia . Cancer 30:288-293, 1972 thalmus in leukaemia. Ophthalmotogica (Basel) 177 :224-228,
15 . Cant JS : Dacryocystitis in acute leukaemia . Br J Ophthalmol 1978
4757-59, 1963 45 . Holbrook CT, Elsas FJ, Crist WM, et al : Acute leukemia and
16 . Cavdar AO, Gozdasoglu S, Arcasoy A, et al : Chloroma-like hypopyon . J Pediat 93 :626-628, 1978
ocular manifestations in Turkish children with acute myelo- 46. Holland JF : Acute leukemias, in Beeson PB, McDermott W,
monocytie leukaemia . Lancet 1 :680-682, 1971 Wyngaarden JB (eds) : Textbook of Medicine. Philadelphia, WB
17 . Chalfin AI, Nash BM, Goldstein JH : Optic nerve head in- Saunders, 1979, ed 15, pp 1813-1821
volvement in lymphocytic leukemia . JPed Ophthalmol 10 :39-43, 47 . Holt JM, Gordon-Smith EC : Retinal abnormalities in diseases
1973 of the blood. Br J Ophthalmol 53 :145-160, 1969
18 . Chumbley LC : Ophthalmology in Internal Medicine. Philadelphia, 48 . Hopen G, Mondino BJ, Johnson BL, et al : Corneal toxicity
WB Saunders, 1981, pp 192-194 with systemic cytarabine . Am J Ophthalmol 97 :500-504, 1981
19 . Clayman HM, Flynn . ]T, Koch K, et al : Retinal pigment epi- 49 . Huguley CM Jr: The chronic leukemias, in Beeson PB,
thelial abnormalities in leukemic disease . Am J Ophthalmol McDermott W, Wyngaarden JB (eds) : Textbook of Medicine .
74 :416-419, 1972 Philadelphia, WB Saunders, 1979, ed 15, pp 1821-1826
20 . Cogan DG: Immunosuppression and eye disease . Am J Oph- 50. Hyman CB, Bogle JM, Brubaker CA, et al : Central nervous
thalmol83 :777-788, 1977 system involvement by leukemia in children . I . Relationship to
21 . Culler AM : Fundus changes in leukemia . Tram Am Ophthalmol systemic leukemia and description of clinical and laboratory
So( 4.9 :445-473, 1951 manifestations . Blood 25 :1-12, 1965
22 . Cullis CM, Hines DR, BullockJD: Anterior segment ischemia : 51 . Jacobs DS, Vastine DW, Urist MJ : Anterior segment ischemia
Classification and description in chronic myelogenous leuke- and sector iris atrophy : After strabismus surgery in a patient
mia . Ann Ophthalmol 11 : 1739-1744, 1979 with chronic lymphocytic leukemia . Ophthal Surg 7(4) :42-48,
23 . Dawson DM, Rosenthal DS, Moloney WC : Neurological com- 1976
plications of acute leukemia in adults : Changing rates . Ann Int 52 . Jakohiec FA, Jones IS : Lymphomatous plasmacytic, histiocy-
Med 79:541-544, 1973 tic, and hematopoietic tumors, injuries IS, Jakobiec FA (eds) :
24, de Juan E, Green W R, Rice TA, et al : Optic disc neovasculari- Diseases of the Orbit . Hagerstown Md, Harper and Row, 1979,
zation associated with ocular involvement in acute lymphocy- pp 309-353 (see pp 345-348)
tic leukemia . Retina 2:61-64,1982 53 . Jampol LM, Goldberg MF, Busse B : Peripheral retinal mi-
25. Deitch RD, Wilson FM : Leukemic reticuloendotheliosis with croaneurysms in chronic leukemia . Am J Ophthalmol 80:242-
presenting ocular complaints . Arch Ophthalmol 69:560-563, 248, 1975
1963 54 . Jampol LM, Goldbaum MH: Peripheral proliferative retinop-
26 . Deutsch AR : Atypical ocular signs as the initial manifestation athies . Sum Ophthalmol 25:1-14, 1980
of serious systemic diseases . Eye Ear Nose Throat Monthly 55 . Johnston SS, Ware CF : Iris involvement in leukaemia . Br J
50 :200-205, 1971 Ophthalmot 57:320-324, 1973
27 . Duane TD, Osher RH, Green WR: White centered hemor- 56 . Kearney WF : Leukemic hypopyon . Am J Ophthalmol 59:495-
rhages : Their significance . Ophthalmology 87:66-69, 1980 497, 1965
28 . Duke JR, Wilkinson CP, Sigelman S : Retinal microaneurysms 57 . Kincaid MC, Green WR, Kelley JS : Acute ocular leukemia .
in leukaemia . By J Ophthalmol .52 :368-374, 1968 Ans . / Ophthalmnl R7: fi98-702, 1979
29. Duke-Elder S : System ofOphthalmology. Cornea and Conjunctiva . Vol 58 . Knox DL : Optic nerve manifestations of systemic diseases .
VIII . St Louis, CV Mosby, 1965, pp 1190-1195 Trans Am Acad Ophthalmol Otolaryngol 83:743-750, 1977
30. Duke-Elder S : System of Ophthalmology . Urea . Vol IX. St . Louis, 59, Kuwabara T, Aiello L : Leukemic miliary nodules in the retina .
CV Mosby, 1966, pp 634-640 Arch Ophthalmot 72:494-497, 1964
31 . Duke-Elder 5 : System of Ophthalmology. Retina . Vol X. St Louis, 60
. Leveille AS, Morse PH : Platelet-induced retinal neovasculari-
CV Mosby, 1967, pp 387-393 zation in leukemia . Am J Ophthalmol 91 :640-643, 1981
32 . Egbert PR, Pollard RB, Gallagher JG, et al : Cytomegalovirus 61 . Lever WF, Schaumburg-Lever G : Histopathology of the Skin .
retinitis in immunosuppressed hosts . 11 . Ocular manifesta- Philadelphia, JB Lippincott, 1975, ed 5, pp 705-707
tions . Ann Jut Med 93 :664-670, 1980 62 . Little HI . : The role of abnormal hemorrheodynamics in the
33 . Eichholtz W : Papillenschwellungen bei Leukamien and ver- pathogenesis of diabetic retinopathy . Traps Am Ophthalmol Soc
wandten Prozessen . Ophthalmologica (Basel) 170 :494-504, 1975 74 :573-636 . 1976
34 . Ellis W, Little HL : Leukemic infiltration of the optic nerve 63 . Liu Fl, Ishimaru T, McGregor DH, et al : Autopsy study of
head . Am J Ophthalmol 75 :867-871, 1973 granulocytic sarcoma (chloroma) in patients with myelogen-
ous leukemia: Hiroshima-Nagasaki 1949-1969 . Cancer 31 :948- Am Acad Ophthalmol Otolagngol 76:652-671, 1972
955, 1973 90 . Saradarian AV : Bilateral suhconjunctival lymphoid infiltra-
64 . Mahneke A, Videboek A : On changes in the optic fundus in tion : Report of a case . Arch Ophthalmol 24 :980-983, 1940
leukaemia . Acta Ophthalmol 42:201-210, 1964 91 . Shaw RK, Moore EW, Freireich EJ, et al : Meningeal leuke-
65 . Mann RB, Jaffe ES, Berard CW : Malignant lymphomas . A mia. Neurology 10:: 823-833, 1960
conceptual understanding of morphologic diversity. A review . 92 . Stirling ML, Parker AC, Keller AJ, et al : Leukapheresis for
Am J Pathol 94:105-192, 1979 papilloedema in chronic granulocytic leukaemia . Br Med j
66 . Mark LE, Ronhani J, Sawitsky A : Leukemic iris infiltration in 2.:676-677, 1977
a case of meningeal leukemia, Ann Ophthalmol 6:669-674, 1974 93 . Sullivan KM, Shulman HN, Storb R, et al : Chronic graft-
67 . Martin B : Infiltration of the iris in chronic lymphatic leukae- versus-host disease in fifty-two patients: Adverse natural
mia . Br J Ophthalmol 52: 781-785, 1968 course and successful treatment with combination immune-
68 . Masera G, Carnelli V, Uderzo C, et al : Leukaemic hypopyon suppression. Blood 57:267-276, 1981
in acute lymphoblastic leukaemia after interruption of treat- 94 . Swartz M, Jampol LM : Comma-shaped venular segments of
ment. Arch Das Child 54:73-74, 1979 conjunctiva in chronic granulocytic leukemia . Can JOphthalmal
69 . Meredith TA, Aaberg TM, Reeser FH: Rhegmatogenous ret- 10 :458-461, 1975
inal detachment complicating cytomegalovirus retinitis . Am J 95 . Swartz M, Schumann GB : Acute leukemic infiltration of the
Ophthalmol87:793-796, 1979 vitreous diagnosed by pans plans aspiration . Am J Ophlhalmol
70 . Michelson PE, Stark W, Reeser F, et al : Endogenous Candida 90 :326-330, 1980
endophthalmitis: Report of 13 cases and 16 from the literature . 96 . Tabbara KF, Beckstead JH : Acute promonocytic leukemia
At Ophthal Clin 11 :125-147, 1971 with ocular involvement . Arch Ophthalmol98: 1055-1058, 1980
71
. Mondino BJ, Brown SI, Mondzelewski JP: Peripheral corneal 97 . Taylor D, Day S, Tiedemann K, et al : Chorioretinal biopsy in
ulcers with herpes zoster ophthalmicus . Am J Ophthalmol a patient with leukaemia . Br J Ophthalmol 65:489-493, 1981
86 :611-614, 1978 98 . Wolintz AH, Goldstein JH, Seligman BR, et al : Secondary
72 . Morse PH, McCready JL : Peripheral retinal neovasculariza- glaucoma in leukemia. Ann Ophthalmol 3:1211-1213, 1971
tion in chronic myelocytic leukemia. Am .] Ophthalmol72:975- 99 . Wood 1M1J, Nicholson DH : Corneal ring ulcer as the presenting
978, 1971 manifestation of acute mynocytic leukemia . Am J Ophthalmol
73 . Mortada A : Orbital lymphoblastomas and acute leukemias in 76:69-72, 1973
J
children . Am Ophthalmal 55:327-331, 1963 100 . Zakka KA, Yee RD, Shoot N, et al : Leukemic iris infiltration .
74 . Murray KH, Paolino F, Goldman _JM, et al : Ocular involve- Am J Ophthalmol 89 :204-209, 1980
ment in leukaemia : Report of three cases . Lancet 1 :829-831, 101 . Zimmerman LE, Font RL : Ophthalmologic manifestations of
1977 granulocytic sarcoma (myeloid sarcoma or chloroma) . Am J
75 . Newberger PE, Latt SA, Pesando jM, et al : Leukemia relapse Ophthalmol 80 :975-990, 1975
in donor cells after allogeneic hone marrow transplantation . 102 . Zimmerman LE, Thorcson HT: Sudden loss of vision in acute
New Engl J .Wed 304 :712-714, 1981 leukemia : A clinicopathologic report of two unusual cases . Sure
76 . Newman NM, Smith ME, Gay AJ : An unusual case of leuke- Ophthalmol9:467-473, 1964
mia involving the eye : A clinico-pathological study . Sum Oph-
thalmol 16:316-321, 1972 Outline
77 . Ninane J, Taylor D, Day S : The eye as a sanctuary in acute
lymphoblastic leukaemia . Lancet 1 :452-453, 1980 I . Systemic leukemia and classification
78 . O'Rourke JF, O'Connor GR : Unusual ocular involvement in II . Ocular involvement : Methods, results, and review
acute lymphatic leukemia, Arch Ophthalmol57 :585-589, 1957 A. Retina
79 . Perry HD, Mallen FJ : Iris involvement in granulocytic sarco- B . Choroid
J
ma . Am Ophthalmol 87.530-532, 1979 C. Iris and anterior segment
80 . Podos SM, Canellos GP: Lens changes in chronic granulocytic
D. Optic nerve and central nervous system
leukemia : Possible relationship to chemotherapy . Am J Oph-
E. Orbit
Oha1mo168:500-504, 1969
F. Cornea and sclera
81 . Porter EA : Acute leukaemia presenting with papilloedema :
Case report . New Zeal Med j 71 :138-140, 1970 G. Conjunctiva
82. Preston FE, Sokol RJ, LilleymanJS et al : Cellular hyperviscos- H. Other ocular manifestations
ity as a cause of neurological symptoms in leukaemia . Br MedJ I. Opportunistic infections
1:476-478, 1978 J. Therapy of ocular involvement
83 . Ravindranathan MP, Paul VJ, Kuriakose ET : Cataract after K. Drug toxicity
busulphan treatment . Br Med J 1 :218-219, 1972 L. Bone marrow transplant and graft-versus-host
84 . Reese AB, Guy L : Exophthalmos in leukemia . Am ]Ophthalmol
disease
16:718-720, 1933
III . Conclusion
85 . Ridgway EW, Jafe N, Walton DS : Leukemic ophthalmopathy
in children . Cancer 38 :1744-1749, 1976
86 . Robb RM, Ervin LD, Sallan SE : A pathological study of eye
involvement in acute leukemia of childhood . TransAm Ophihal-
mol Soc 76:90-101, 1978 Supported in part by a Heed Fellowship (Dr . Kincaid) and re-
87 . Rosenthal AR, Egbert PR, WilburJR, et al : Leukemic involve- search grant I R01-EY01804, National Eye Institute (Dr. Green) .
ment of the optic nerve . J Ped Ophthalmol 12(2) :84-93, 1975 Dr. Kincaid is currently Assistant Professor of Ophthalmology and
88 . Rowan PJ, Sloan JB : Iris and anterior chamber involvement in Pathology at the University of Texas in San Antonio .
leukemia . Ann Ophthalmol 8 :1081-1085, 1976 Reprint requests should be addressed to W . Richard Green,
89 . Ryan SJ, Zimmerman LE, King FM : Reactive lymphoid hy- M .D ., Eye Pathology Laboratory, Wilmer Institute, Johns Hopkins
perplasia : An unusual form of intraocular pseudotumor. Traps Hospital, 600 N . Wolfe St ., Baltimore, MD 21205 .